CY1125418T1 - Αλατα του 6-(2,4-διχλωροφαινυλο)-5-[4-[(3s)-1-(3- φθοροπροπυλο)πυρρολιδιν-3-υλ]οξυφαινυλο]-8,9- διυδρο-7η-βενζο[7]αννουλενο-2-καρβοξυλικου μεθυλεστερα και διαδικασια παρασκευης αυτων - Google Patents
Αλατα του 6-(2,4-διχλωροφαινυλο)-5-[4-[(3s)-1-(3- φθοροπροπυλο)πυρρολιδιν-3-υλ]οξυφαινυλο]-8,9- διυδρο-7η-βενζο[7]αννουλενο-2-καρβοξυλικου μεθυλεστερα και διαδικασια παρασκευης αυτωνInfo
- Publication number
- CY1125418T1 CY1125418T1 CY20221100508T CY221100508T CY1125418T1 CY 1125418 T1 CY1125418 T1 CY 1125418T1 CY 20221100508 T CY20221100508 T CY 20221100508T CY 221100508 T CY221100508 T CY 221100508T CY 1125418 T1 CY1125418 T1 CY 1125418T1
- Authority
- CY
- Cyprus
- Prior art keywords
- annulene
- oxyphenyl
- fluoropropyl
- pyrrolidin
- dichlorophenyl
- Prior art date
Links
- OCQAXYHNMWVLRH-UHFFFAOYSA-N 2,3-dibenzoyl-2,3-dihydroxybutanedioic acid Chemical compound C=1C=CC=CC=1C(=O)C(O)(C(O)=O)C(O)(C(=O)O)C(=O)C1=CC=CC=C1 OCQAXYHNMWVLRH-UHFFFAOYSA-N 0.000 abstract 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 abstract 1
- PAFURZJCCMSKNY-SANMLTNESA-N methyl 6-(2,4-dichlorophenyl)-5-[4-[(3S)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylate Chemical class COC(=O)C1=CC=C2C(CCCC(C3=C(Cl)C=C(Cl)C=C3)=C2C2=CC=C(O[C@H]3CCN(CCCF)C3)C=C2)=C1 PAFURZJCCMSKNY-SANMLTNESA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/1616—Coordination complexes, e.g. organometallic complexes, immobilised on an inorganic support, e.g. ship-in-a-bottle type catalysts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/06—Oxalic acid
- C07C55/07—Salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/255—Tartaric acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Health & Medical Sciences (AREA)
- Pyrrole Compounds (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Στο παρόν έγγραφο παρέχονται καινοτόμα άλατα του 6-(2,4-διχλωροφαινυλο)-5-[4-[(3S)-1-(3- φθοροπροπυλο)πυρρολιδιν-3-υλ]οξυφαινυλο]-8,9-διυδρο-7Η-βενζο[7] αννουλενο-2-καρβοξυλικού μεθυλεστέρα, δηλαδή το οξαλικό άλας (Ι) και το διβενζοϋλοτρυγικό άλας (II).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18306177 | 2018-09-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1125418T1 true CY1125418T1 (el) | 2024-09-20 |
Family
ID=63637829
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20221100508T CY1125418T1 (el) | 2018-09-07 | 2022-07-26 | Αλατα του 6-(2,4-διχλωροφαινυλο)-5-[4-[(3s)-1-(3- φθοροπροπυλο)πυρρολιδιν-3-υλ]οξυφαινυλο]-8,9- διυδρο-7η-βενζο[7]αννουλενο-2-καρβοξυλικου μεθυλεστερα και διαδικασια παρασκευης αυτων |
| CY20221100558T CY1125486T1 (el) | 2018-09-07 | 2022-08-18 | Διαδικασια για την παρασκευη 6-(2,4- διχλωροφαινυλο)-5-[4-[(3s)-1-(3- φθοροπροπυλο)πυρρολιδιν-3-υλ|οξυφαινυλο]-8,9- διυδρο-7η-βενζο[7]αννουλενο-2-καρβοξυλικου μεθυλεστερα κι ενος αλατος αυτου |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20221100558T CY1125486T1 (el) | 2018-09-07 | 2022-08-18 | Διαδικασια για την παρασκευη 6-(2,4- διχλωροφαινυλο)-5-[4-[(3s)-1-(3- φθοροπροπυλο)πυρρολιδιν-3-υλ|οξυφαινυλο]-8,9- διυδρο-7η-βενζο[7]αννουλενο-2-καρβοξυλικου μεθυλεστερα κι ενος αλατος αυτου |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US11713296B2 (el) |
| EP (2) | EP3847156B1 (el) |
| JP (2) | JP7398436B2 (el) |
| KR (2) | KR20210057031A (el) |
| CN (2) | CN112638869A (el) |
| AR (2) | AR116300A1 (el) |
| AU (2) | AU2019335542A1 (el) |
| BR (2) | BR112021003061A2 (el) |
| CA (2) | CA3111466A1 (el) |
| CY (2) | CY1125418T1 (el) |
| DK (2) | DK3847156T3 (el) |
| ES (2) | ES2923412T3 (el) |
| HU (2) | HUE059362T2 (el) |
| IL (2) | IL281191B (el) |
| MX (2) | MX2021002666A (el) |
| SG (2) | SG11202102057SA (el) |
| TW (2) | TWI803692B (el) |
| WO (2) | WO2020049153A1 (el) |
| ZA (2) | ZA202101006B (el) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3434272A1 (en) | 2017-07-25 | 2019-01-30 | Sanofi | Combination comprising palbociclib and 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulene-2-carboxylic acid |
| AU2019335542A1 (en) | 2018-09-07 | 2021-04-01 | Sanofi | Process for the preparation of methyl 6-(2,4-dichlorophenyl)-5-(4-((3s)-1-(3-fluoropropyl)pyrrolidin-3-yl)oxyphenyl)-8,9-dihydro-7H-benzo(7)annulene-2-carboxylate |
| BR112022009705A2 (pt) | 2019-12-09 | 2022-08-09 | Sanofi Sa | Forma cristalina anidra de um derivado de ácido 7h-benzo[7]anuleno-2-carboxílico, seus usos e processos de preparação, forma sólida, medicamento e composição farmacêutica |
| WO2022001971A1 (zh) | 2020-06-28 | 2022-01-06 | 南京明德新药研发有限公司 | 并环吲唑类化合物 |
| CA3196092A1 (en) | 2020-10-19 | 2022-04-28 | Patrick Bernardelli | Substituted 6,7-dihydro-5h-benzo[7]annulene compounds and their derivatives, processes for their preparation and therapeutic uses thereof |
| EP4228758B1 (en) | 2020-10-19 | 2024-07-24 | Sanofi | Substituted 6,7-dihydro-5h-benzo[7]annulene compounds and their derivatives, processes for their preparation and therapeutic uses thereof |
| EP4458821A1 (en) | 2021-12-28 | 2024-11-06 | Shenzhen Vybio Pharmaceutical Technology Co., Ltd. | Salt form and crystal form of tetrahydrocyclohepta indazole compound |
| WO2023187086A1 (en) | 2022-03-31 | 2023-10-05 | Sanofi | Amorphous solid form of amcenestrant |
| WO2023198904A1 (en) * | 2022-04-15 | 2023-10-19 | Sanofi | Substituted 6,7-dihydro-5h-benzo[7]annulene derivatives, processes for their preparation and therapeutic uses thereof |
| WO2023198901A1 (en) | 2022-04-15 | 2023-10-19 | Sanofi | Novel substituted 4-amino-4-oxo-but-2-enyl derivatives, processes for their preparation and therapeutic uses thereof |
| WO2023198903A1 (en) | 2022-04-15 | 2023-10-19 | Sanofi | Novel substituted fluorinated n-propyl-pyrrolidine and n‑propyl-azetidine compounds, processes for their preparation and therapeutic uses thereof |
| WO2023198905A1 (en) | 2022-04-15 | 2023-10-19 | Sanofi | Novel substituted fluorinated vinyl-n-propyl-pyrrolidine compounds, processes for their preparation and therapeutic uses thereof |
| WO2023198879A1 (en) | 2022-04-15 | 2023-10-19 | Sanofi | Novel substituted fluorinated n-propyl-pyrrolidine compounds, processes for their preparation and therapeutic uses thereof |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992015579A1 (en) | 1991-03-08 | 1992-09-17 | Rhone-Poulenc Rorer International (Holdings) Inc. | Multicyclic tertiary amine polyaromatic squalene synthetase inhibitors |
| DE19833786A1 (de) | 1998-07-18 | 2000-01-20 | Schering Ag | Benzocycloheptene, Verfahren zu ihrer Herstellung, pharmazeutische Präparate, die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln |
| EP1229036B1 (en) | 2001-01-24 | 2005-01-12 | CHIESI FARMACEUTICI S.p.A. | 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
| EE200400061A (et) | 2001-08-11 | 2004-04-15 | Bristol-Myers Squibb Pharma Company | Trifenüületüleeni derivaadid kui selektiivsed östrogeeniretseptori modulaatorid ja neid sisaldavad ravimkoostised |
| DK1501819T3 (da) | 2002-04-24 | 2011-01-10 | Merck Sharp & Dohme | Østrogenreceptormodulatorer |
| CA2512000C (en) | 2002-12-26 | 2011-08-09 | Eisai Co., Ltd. | Selective estrogen receptor modulator |
| BRPI0512623A (pt) | 2004-06-25 | 2008-03-25 | Janssen Phamaceutica N V | sal quaternário antagonista de ccr2 |
| US7429681B2 (en) | 2005-06-14 | 2008-09-30 | Baylor University | Combretastatin analogs with tubulin binding activity |
| US8127618B1 (en) | 2007-05-18 | 2012-03-06 | Pacesetter, Inc. | Implantable micro-electromechanical system sensor |
| EP2048126A1 (de) | 2007-10-11 | 2009-04-15 | Bayer Schering Pharma AG | Benzocycloheptanderivate als selektiv wirksame Estrogene |
| WO2009101634A2 (en) | 2008-02-13 | 2009-08-20 | Lupin Limited | A novel process for the preparation of eszopiclone |
| DE102010030538A1 (de) | 2010-06-25 | 2011-12-29 | Bayer Schering Pharma Aktiengesellschaft | 6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln |
| GB2483736B (en) | 2010-09-16 | 2012-08-29 | Aragon Pharmaceuticals Inc | Estrogen receptor modulators and uses thereof |
| WO2012068284A2 (en) | 2010-11-16 | 2012-05-24 | Baylor University | Efficient method for preparing functionalized benzosuberenes |
| AU2011347718B2 (en) | 2010-12-24 | 2016-06-23 | Msd Oss B.V. | N-substituted azetidine derivatives |
| DE102011087987A1 (de) | 2011-12-08 | 2013-06-13 | Bayer Intellectual Property Gmbh | 6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln |
| CN102584687A (zh) | 2011-12-30 | 2012-07-18 | 北京赛林泰医药技术有限公司 | 作为选择性雌激素受体调节剂的乙烯衍生物 |
| JP2015504049A (ja) | 2011-12-30 | 2015-02-05 | センタウルス・バイオファーマ・カンパニー・リミテッドＣｅｎｔａｕｒｕｓ Ｂｉｏｐｈａｒｍａ Ｃｏ．，Ｌｔｄ． | 新規アリールアルケン誘導体およびその選択的エストロゲン受容体調整剤における使用 |
| CN110368497B (zh) | 2013-08-14 | 2022-05-13 | 诺华股份有限公司 | 用于治疗癌症的组合疗法 |
| WO2015028409A1 (de) | 2013-08-27 | 2015-03-05 | Bayer Pharma Aktiengesellschaft | 6,7-dihydro-5h-benzo[7]annulen-derivate, verfahren zu ihrer herstellung, pharmazeutische präparate die diese enthalten, sowie deren verwendung zur herstellung von arzneimitteln |
| CN105916501A (zh) | 2013-12-06 | 2016-08-31 | 豪夫迈·罗氏有限公司 | 用于治疗局部晚期或转移性雌激素受体阳性乳腺癌的雌激素受体调节剂 |
| TWI699363B (zh) | 2014-12-18 | 2020-07-21 | 瑞士商赫孚孟拉羅股份公司 | 四氫-吡啶并［３，４-ｂ］吲哚雌激素受體調節劑及其用途 |
| CN107406424B (zh) | 2014-12-18 | 2020-08-25 | 豪夫迈·罗氏有限公司 | 雌激素受体调节剂及其用途 |
| KR102676705B1 (ko) | 2015-04-29 | 2024-06-18 | 래디어스 파마슈티컬스, 인코포레이티드 | 암을 치료하는 방법 |
| CN106924210A (zh) | 2015-12-29 | 2017-07-07 | 北京新领先医药科技发展有限公司 | 一种含有帕布昔利布的胶囊剂及其制备方法 |
| MX2018009908A (es) | 2016-02-15 | 2018-09-07 | Sanofi Sa | Derivados de 6,7-dihidro-5h-benzo[7]anuleno como moduladores de receptores de estrogenos. |
| JP6946430B2 (ja) | 2016-11-17 | 2021-10-06 | サノフイＳａｎｏｆｉ | 新規の置換ｎ−（３−フルオロプロピル）−ピロリジン化合物、それを製造するための方法、およびその治療的使用 |
| EP3434272A1 (en) | 2017-07-25 | 2019-01-30 | Sanofi | Combination comprising palbociclib and 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulene-2-carboxylic acid |
| AU2019335542A1 (en) | 2018-09-07 | 2021-04-01 | Sanofi | Process for the preparation of methyl 6-(2,4-dichlorophenyl)-5-(4-((3s)-1-(3-fluoropropyl)pyrrolidin-3-yl)oxyphenyl)-8,9-dihydro-7H-benzo(7)annulene-2-carboxylate |
| TW202038951A (zh) | 2018-11-16 | 2020-11-01 | 美商亞闊股份有限公司 | 用於治療癌症之醫藥組合 |
| AU2020268762A1 (en) | 2019-05-09 | 2021-12-02 | Sanofi | 6-(2,4-dichlorophenyl)-5-[4-[(3S)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylic acid for use in metastatic or advanced breast cancer patients |
| CA3148592A1 (en) * | 2019-07-22 | 2021-01-28 | Sun Pharma Advanced Research Company Limited | Selective estrogen receptor degrader |
| US20220389006A1 (en) * | 2019-11-04 | 2022-12-08 | Recurium Ip Holdings, Llc | Salts and forms of an estrogen receptor modulator |
| BR112022009705A2 (pt) * | 2019-12-09 | 2022-08-09 | Sanofi Sa | Forma cristalina anidra de um derivado de ácido 7h-benzo[7]anuleno-2-carboxílico, seus usos e processos de preparação, forma sólida, medicamento e composição farmacêutica |
-
2019
- 2019-09-06 AU AU2019335542A patent/AU2019335542A1/en active Pending
- 2019-09-06 WO PCT/EP2019/073827 patent/WO2020049153A1/en unknown
- 2019-09-06 CN CN201980058342.XA patent/CN112638869A/zh active Pending
- 2019-09-06 MX MX2021002666A patent/MX2021002666A/es unknown
- 2019-09-06 AU AU2019336532A patent/AU2019336532A1/en active Pending
- 2019-09-06 WO PCT/EP2019/073823 patent/WO2020049150A1/en unknown
- 2019-09-06 SG SG11202102057SA patent/SG11202102057SA/en unknown
- 2019-09-06 BR BR112021003061-1A patent/BR112021003061A2/pt not_active IP Right Cessation
- 2019-09-06 EP EP19765710.9A patent/EP3847156B1/en active Active
- 2019-09-06 HU HUE19765710A patent/HUE059362T2/hu unknown
- 2019-09-06 CA CA3111466A patent/CA3111466A1/en active Pending
- 2019-09-06 ES ES19765710T patent/ES2923412T3/es active Active
- 2019-09-06 HU HUE19765711A patent/HUE059527T2/hu unknown
- 2019-09-06 CA CA3111359A patent/CA3111359A1/en active Pending
- 2019-09-06 CN CN201980058412.1A patent/CN112638870A/zh active Pending
- 2019-09-06 DK DK19765710.9T patent/DK3847156T3/da active
- 2019-09-06 AR ARP190102550A patent/AR116300A1/es unknown
- 2019-09-06 ES ES19765711T patent/ES2924738T3/es active Active
- 2019-09-06 JP JP2021512678A patent/JP7398436B2/ja active Active
- 2019-09-06 EP EP19765711.7A patent/EP3847157B1/en active Active
- 2019-09-06 KR KR1020217006751A patent/KR20210057031A/ko active Search and Examination
- 2019-09-06 TW TW108132201A patent/TWI803692B/zh active
- 2019-09-06 AR ARP190102549A patent/AR116299A1/es unknown
- 2019-09-06 BR BR112021003440-4A patent/BR112021003440A2/pt not_active IP Right Cessation
- 2019-09-06 MX MX2021002665A patent/MX2021002665A/es unknown
- 2019-09-06 JP JP2021512672A patent/JP7413363B2/ja active Active
- 2019-09-06 KR KR1020217006752A patent/KR20210057032A/ko active Search and Examination
- 2019-09-06 DK DK19765711.7T patent/DK3847157T3/da active
- 2019-09-06 SG SG11202102059YA patent/SG11202102059YA/en unknown
- 2019-09-06 TW TW108132203A patent/TW202026280A/zh unknown
- 2019-09-06 IL IL281191A patent/IL281191B/en unknown
-
2021
- 2021-02-15 ZA ZA2021/01006A patent/ZA202101006B/en unknown
- 2021-02-17 ZA ZA2021/01079A patent/ZA202101079B/en unknown
- 2021-03-02 IL IL281196A patent/IL281196B2/en unknown
- 2021-03-05 US US17/193,776 patent/US11713296B2/en active Active
- 2021-03-05 US US17/193,706 patent/US20210188771A1/en active Pending
-
2022
- 2022-07-26 CY CY20221100508T patent/CY1125418T1/el unknown
- 2022-08-18 CY CY20221100558T patent/CY1125486T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1125418T1 (el) | Αλατα του 6-(2,4-διχλωροφαινυλο)-5-[4-[(3s)-1-(3- φθοροπροπυλο)πυρρολιδιν-3-υλ]οξυφαινυλο]-8,9- διυδρο-7η-βενζο[7]αννουλενο-2-καρβοξυλικου μεθυλεστερα και διαδικασια παρασκευης αυτων | |
| AR057996A1 (es) | Compuestos, composiciones pesticidas y metodo par combatir pestes | |
| CY1123426T1 (el) | Μεθοδος για τη ληψη κρυσταλλων αλατος μεγλουμινης του 1-(5,6-διχλωρο-1η-βενζο[d]ιμιδαζολ-2-υλο)-1η-πυραζολο-4-καρβοξυλικου οξεος | |
| CY1118416T1 (el) | Υποκατεστημενες 4-φαινυλο-πυριδινες για τη θεραπεια ασθενειων που σχετιζονται με τον νκ-1 υποδοχεα | |
| EA201590330A1 (ru) | Соли и твердые формы (s)-3-(4-((4-(морфолинометил)бензил)окси)-1-оксоизоиндолин-2-ил)пиперидин-2,6-диона и включающие их композиции и способы их применения | |
| ATE358479T1 (de) | 1-(2,3-dimethyl-phenyl)-ethyl-1,3-dihydro- imidazol-2-thion als nicht-sedierender alpha 2a agonist | |
| CY1118621T1 (el) | Πολυμορφικες μορφες του 2-(5-βρωμο-4-(4-κυκλο προπυλναφθαλιν-1-υλ)-4η-1,2,4-τριαζολ-3-υλθειο) οξικου οξεος και χρησεις αυτων | |
| EA201890086A1 (ru) | 1,4-замещенные производные пиперидина | |
| EA202092620A1 (ru) | Соли и твердые формы монобактамного антибиотика | |
| EA201790290A1 (ru) | Формерные соли (2s,3s)-метил 7-фтор-2-(4-фторфенил)-3-(1-метил-1h-1,2,4-триазол-5-ил)-4-оксо-1,2,3,4-тетрагидрохинолин-5-карбоксилата и способы их получения | |
| CY1113757T1 (el) | Παραγωγα πιπεριδινης και πιπεραζινης για τη θεραπεια ογκων | |
| CY1124984T1 (el) | Αμινοïμιδαζοπυριδινες ως αναστολεις κινασων | |
| EA200801691A1 (ru) | Соль янтарной кислоты 1-[2-(2-хлор-4-{[(r)-2-гидрокси-2-(8-гидрокси-2-оксо-1,2-дигирдохинолин-5-ил)этиламино]метил}-5-метоксифенилкарбамоил)этил]пиперидин-4-илового эфира бифенил-2-илкарбаминовой кислоты и ее применение для лечения легочных расстройств | |
| CY1113622T1 (el) | Κρυσταλλικη μορφη μιας ενωσης 4-[2-(2-φθοροφαινοξυμεθυλο)φαινυλο]πιπεριδινης | |
| EA201791226A1 (ru) | Композиции, содержащие 2-((1-(2-(4-фторфенил)-2-оксоэтил)пиперидин-4-ил)метил)изоиндолин-1-он для лечения шизофрении | |
| CL2018001067A1 (es) | Compuesto piranodipiridínico. | |
| CY1124397T1 (el) | Κρυσταλλικο (2s,4r)-5-(5'-χλωρο-2-φθορο-[1,1'-διφαινυλ] -4-υλ)-2-(αιθοξυμεθυλ)-4-(3-υδροξυϊσοξαζολη-5- καρβοξαμιδο) -2-μεθυλπεντανοϊκο οξυ και χρησεις αυτου | |
| EA200900985A1 (ru) | Способ получения оптически чистого омепразола | |
| CY1109154T1 (el) | Μικροκαψουλες για την καθυστερημενη και ελεγχομενη απελευθερωση της περινδοπριλης | |
| CY1111919T1 (el) | Ηλεκτρικο αλας της 2-((4-(1-μεθυλ-4-(πυριδιν-4-υλ)-1η-πυραζολ-3-υλ)-φαινοξυ)μεθυλ)κινολινης | |
| PE20070713A1 (es) | 4-amino-5-cloro-n-{[1-(tetrahidro-2h-piran-4-ilmetil)-4-piperidinil]metil}-1-benzofuran-7-carboxamida en el tratamiento de alzheimer | |
| CL2021001689A1 (es) | Ácido r-piridiloxicarboxílico y sal, derivado del éster, método de preparación, composición herbicida y aplicación del mismo. | |
| CL2020000618S1 (es) | Cabezal de cepillo de dientes. (divisional solicitud 201900807) | |
| CL2020000617S1 (es) | Cabezal de cepillo de dientes. (divisional solicitud 201900806) | |
| CL2020000620S1 (es) | Cabezal de cepillo de dientes. (divisional solicitud 201900808) |